Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check2 days agoChange DetectedA new revision entry (v3.5.4) dated 2026-05-08 with an added 'Study Status' section appears in the history, replacing the prior revision entry (v3.5.3) dated 2026-04-13.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study history now shows a new revision tag (v3.5.3), indicating a minor update to the page version of the record.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA new history entry was added for Study Status with Revision v3.5.2 (dated 2026-04-13), and the prior Revision v3.5.0 was removed (dated 2026-03-12).SummaryDifference0.2%

- Check59 days agoChange DetectedA new version entry dated 2026-03-12 for Study Status (revision v3.5.0) was added to the history, and the prior 2026-02-13 revision (v3.4.3) was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed in the page history. This is a system version update rather than a change to trial data.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded a new 2026-02-13 entry for Study Status in the record history. A deletion dated 2026-01-16 is also shown.SummaryDifference0.2%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.